Search

Search Constraints

You searched for: Record Type Journal Article Author/Creator Gormley, Matthew

Search Results

1. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. (March 2021)